Supraventricular tachycardia after withdrawal of prolonged dexmedetomidine infusion in a paediatric patient without heart disease | Zendy

FloresGonzález J. Carlos | Zendy; EstalellaMendoza Ana | Zendy; LechugaSancho Alfonso M. | Zendy; HernándezGonzález Arturo | Zendy; RubioQuiñones Fernando | Zendy; RodríguezCampoy Patricia | Zendy; SaldañaValderas Mónica | Zendy

Premium

Supraventricular tachycardia after withdrawal of prolonged dexmedetomidine infusion in a paediatric patient without heart disease

Author(s) -

FloresGonzález J. Carlos,

EstalellaMendoza Ana,

LechugaSancho Alfonso M.,

HernándezGonzález Arturo,

RubioQuiñones Fernando,

RodríguezCampoy Patricia,

SaldañaValderas Mónica

Publication year - 2017

Publication title -

journal of clinical pharmacy and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.622

H-Index - 73

eISSN - 1365-2710

pISSN - 0269-4727

DOI - 10.1111/jcpt.12564

Subject(s) - medicine , dexmedetomidine , supraventricular tachycardia , anesthesia , respiratory distress , heart disease , tachycardia , adverse effect , paroxysmal supraventricular tachycardia , acute respiratory distress , bradycardia , cardiology , heart rate , sedation , lung , blood pressure

Summary What is known and objective Dexmedetomidine ( DEX ) has been reported to be safe in paediatric patients. Case description We present the case of a girl without heart disease admitted at our PICU due to an influenza A acute respiratory distress syndrome, who suffered a paroxysmal supraventricular tachycardia ( PSVT ) twelve hours after DEX progressive withdrawal was completed. What is new and Conclusion This is the first report of PSVT as an adverse reaction to DEX in a paediatric patient without heart disease.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research